Narita Memorial Proton Center in Toyohashi, Japan, has treated its first patient using planning in RayStation. The system was used to plan a pencil beam scanning treatment (PBS) which was delivered to a prostate cancer patient by the IBA Proteus®ONE compact proton therapy solution.

The center was established in April 2018, and this first patient treatment was conducted in early September.

The RayStation system at Narita Memorial Proton Center includes multi criteria optimization (MCO), which seeks to decrease manual planning time, provide a better understanding of tradeoffs between conflicting planning goals, and improve treatment plan quality.

Japan is one of the world's most technologically advanced treatment planning markets, and particle planning is continuously growing in the region. RaySearch has a strong user base in Japan and is a
world-wide market leader for proton therapy planning software. 
Read more

The University of California, San Francisco (UCSF), has added RayStation-licenses for expansion at UCSF Medical Center at Mission Bay, California. These licenses add to the existing wide area network infrastructure, as a new facility that will open in 2019, will use RayStation for treatment planning.

This is the third UCSF facility to use RayStation, in addition to the existing centers at UCSF Medical Center at Mount Zion and UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco. Their vision is “Three campuses with one mission”– which will be put into practice by utilizing advanced technologies such as adaptive therapy, advanced automatic planning tools such as Plan Explorer, Fallback Planning and Autobreast planning.

Johan Löf, CEO of RaySearch, says: “UCSF has been a very important partner for us, both for RayStation as well as for RayCare*, our new oncology information system. We are excited to continue our collaboration and give them the best support as they introduce new centers and modalities in the San Francisco area.”
Read more

UMC Groningen (UMCG) has started treating patients using the treatment planning system (TPS) RayStation's feature Plan Explorer. The center utilizes Plan Explorer for prostate cases, using VMAT. So far, approximately 60 patients have been treated.

UMCG has been a RaySearch-client since 2013 and use RayStation as their main TPS for external beam proton and photon radiotherapy. The RayStation installation at the center includes adaptive radiation therapy, multi-criteria optimization and radiobiology, in complement to the Plan Explorer feature. The center is also equipped with 9 Elekta-linacs and an IBA Proteus® Plus with two gantry rooms.

Since becoming a customer, the center has been closely involved with development in the RaySearch headquarters in Stockholm, Sweden. UMCG and RaySearch currently have a research collaboration about Plan Explorer, and the center is also a clinical collaboration partner in the development of the next oncology information system RayCare.
Read more

The CIRS Dynamic cardiac phantom is a precision instrument that simulates the realistic motion of an average human heart  It provides known, accurate and repeatable 3D motion of a solid heart model inside the tissue equivalent thorax phantom.  This model is designed as a comprehensive image analysis tool for calcification detection, iodine contrast resolution and ECG signal gating.  The cardiac phantom is constructed from the tissue equivalent thorax body, moving rod with the solid, tissue equivalent heart inside, motion actuator, motion controller and CIRS Motion control software.

Features:

• Anthropomorphic heart inside a thorax body
• Tissue equivalent materials
• Contrast target interchangeability
• Complex heart motion combined with respiratory motion
• Sub-millimetre accuracy and reproducibility
• Motion software enables different cycles, amplitudes and wave forms
• Correlated ECG signal and readable output

The board integrates with the Monarch Overhead Arm Positioner to provide an efficient approach for arms-up positioning, allowing for proper superior/inferior adjustment of the board to the patient which helps reduce patient slide. The board is MRI compatible, which allows hospitals to   The board features an enhanced bottom stop.  The C-Qual M assists in providing comfortable, reproducible patient positioning for supine breast treatment.future proof their departments for the future use of MRI within Radiotherapy. The C-Qual M also provides the user with a significantly higher weight limit than previous CIVCO boards, which is useful for larger patients.

For further product information, images and a video click here.

Contact Jessica Johnson - Marketing Manager at IEL

Diverse studies demonstrate transformative potential for MR/RT in various cancer indications to deliver radiation to a variety of tumor types while protecting nearby tissues and organs

Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system was featured in 11 abstracts at the American Society for Radiation Oncology (ASTRO) Annual Meeting, which took place October 21-24 in San Antonio, Texas. Elekta Unity, which received CE Mark in June 2018 and currently pending U.S. FDA 510(k) premarket clearance, is the first high-field MR/RT system that allows clinicians to see and track difficult-to-visualize soft tissue anatomies in real-time during radiation dosing.

“As a transformative approach to cancer care, clinical implementation of MRgRT requires not only novel hardware and software systems, but also needs clinical evidence to enable treatment that is optimized for specific tumor types and to address the unique anatomy and tumor biology of each patient,” said X. Allen Li, PhD, Chief Physicist, Department of Radiation Oncology at Froedtert & the Medical College of Wisconsin Clinical Cancer Center.
Read more

IDC, the world's leading digital research firm, announced Beijing Cancer Hospital won a "2018 IDC China Digital Transformation Annual Award" in the category of Operating Model Master, for their successful clinical use of Varian's RapidPlan™. Beijing Cancer Hospital was the only winner from healthcare industry in this category.

RapidPlan is a part of Varian's Eclipse™ cancer treatment planning software that uses machine learning to study the best practices from past successful treatment plans and creates intelligent mathematical models that automatically improve the quality of treatment plans for future patients. These RapidPlan models help to quickly generate and validate new high-quality treatment plans based on shared expertise of multiple clinicians.
Read more

Varian today announced the Bravos™ afterloader system for High Dose Rate (HDR) brachytherapy treatments. Based on over five years of in-clinic research, Bravos is an integrated system designed to improve the patient and clinic experience by simplifying brachytherapy treatment and providing greater workflow efficiency.

HDR brachytherapy involves delivering radiotherapy by temporarily placing a tiny radioactive source directly into the tumor or other targeted area. Using an afterloader, clinicians are able to position the radioactive source in a needle, catheter or tumor-specific applicator following a pattern that has been designed to create a highly conformal dose distribution within or on the surface of the patient's anatomy. Once the treatment is completed, the afterloader safely returns the source to the afterloader.
Read more

To expand the encouraging preclinical and translational research already conducted by Varian (NYSE: VAR) and two of its clinical partners, Maryland Proton Treatment Center and Cincinnati Children's/UC Health Proton Therapy Center, on the value of ultra-high dose rate proton therapy for the treatment of cancer, the company has formed the FlashForward™ Consortium. With an initial thirteen members, the consortium is focused on preclinical research, clinical implementation and advocacy efforts of Flash therapy.
Read more

Welcome to Radeya, a name of Arabic origin meaning “to please”, the new radiotherapy information Chatbot from RadPro 365 Live. Our international partner companies and organisations are not open 365 days and 24/7 but we are and our readers want speedy interaction to obtain a quick answer to their radiotherapy information, product and service questions.

As an innovative virtual exhibition and meeting place, we have always wanted to promote a more hands on approach to lead generation ensuring our readers can more easily obtain product or service information from our partner companies and organisations in their mode of choice at any time just as if they are attending a conventional trade show, exhibition, meeting or congress.

Our innovative, new Radeya Chatbot allows readers to interact on a company’s virtual exhibition stand and request information at any time. This request is individually saved as a template and securely passed on to the specific partner company as soon as possible for follow up in the readers preferred communication format.

We know that Individuals are messaging chatbots for many different reasons. However, the key things customers want from chatbots are:

•             To get a quick answer to questions

•             Request specific information in a timely manner

•             To resolve a problem

•             To get a more detailed answer to a query

•             Finding a human customer service agent

Every RadPro partner company can have Radeya on its virtual exhibition stand page and RadPro will manage and forward any information requests to each company as soon as possible.

To use or see how Radeya works, visit the virtual exhibition and click on a company’s stand and you will see this logo:

There are also Chatbots that advice how to send in RadPro 365 Live participation information and so email us at admin@RadPro.eu for more details.